BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

637 related articles for article (PubMed ID: 20237805)

  • 1. A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: prevalence, severity and impact on quality of life.
    Jensen SB; Pedersen AM; Vissink A; Andersen E; Brown CG; Davies AN; Dutilh J; Fulton JS; Jankovic L; Lopes NN; Mello AL; Muniz LV; Murdoch-Kinch CA; Nair RG; Napeñas JJ; Nogueira-Rodrigues A; Saunders D; Stirling B; von Bültzingslöwen I; Weikel DS; Elting LS; Spijkervet FK; Brennan MT;
    Support Care Cancer; 2010 Aug; 18(8):1039-60. PubMed ID: 20237805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: management strategies and economic impact.
    Jensen SB; Pedersen AM; Vissink A; Andersen E; Brown CG; Davies AN; Dutilh J; Fulton JS; Jankovic L; Lopes NN; Mello AL; Muniz LV; Murdoch-Kinch CA; Nair RG; Napeñas JJ; Nogueira-Rodrigues A; Saunders D; Stirling B; von Bültzingslöwen I; Weikel DS; Elting LS; Spijkervet FK; Brennan MT; ; ;
    Support Care Cancer; 2010 Aug; 18(8):1061-79. PubMed ID: 20333412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salivary Gland Hypofunction and/or Xerostomia Induced by Nonsurgical Cancer Therapies: ISOO/MASCC/ASCO Guideline.
    Mercadante V; Jensen SB; Smith DK; Bohlke K; Bauman J; Brennan MT; Coppes RP; Jessen N; Malhotra NK; Murphy B; Rosenthal DI; Vissink A; Wu J; Saunders DP; Peterson DE
    J Clin Oncol; 2021 Sep; 39(25):2825-2843. PubMed ID: 34283635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salivary Gland Hypofunction and Xerostomia in Head and Neck Radiation Patients.
    Jensen SB; Vissink A; Limesand KH; Reyland ME
    J Natl Cancer Inst Monogr; 2019 Aug; 2019(53):. PubMed ID: 31425600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Xerostomia and salivary hypofunction in vulnerable elders: prevalence and etiology.
    Liu B; Dion MR; Jurasic MM; Gibson G; Jones JA
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Jul; 114(1):52-60. PubMed ID: 22727092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioactive iodine: An unappreciated threat to salivary gland function.
    Sunavala-Dossabhoy G
    Oral Dis; 2018 Mar; 24(1-2):198-201. PubMed ID: 29480611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salivary gland and associated complications in head and neck cancer therapy.
    Kumar S; Ram S; Navazesh M
    J Calif Dent Assoc; 2011 Sep; 39(9):639-47. PubMed ID: 22034798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal stem cell therapy for salivary gland dysfunction and xerostomia: a systematic review of preclinical studies.
    Jensen DH; Oliveri RS; Trojahn Kølle SF; Fischer-Nielsen A; Specht L; Bardow A; Buchwald C
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Mar; 117(3):335-342.e1. PubMed ID: 24528792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical effectiveness and safety of acupuncture in the treatment of irradiation-induced xerostomia in patients with head and neck cancer: a systematic review.
    O'Sullivan EM; Higginson IJ
    Acupunct Med; 2010 Dec; 28(4):191-9. PubMed ID: 21062848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Marrow-Derived Autologous Stromal Cells for the Restoration of Salivary Hypofunction (MARSH): Study protocol for a phase 1 dose-escalation trial of patients with xerostomia after radiation therapy for head and neck cancer: MARSH: Marrow-Derived Autologous Stromal Cells for the Restoration of Salivary Hypofunction.
    Blitzer GC; Rogus-Pulia NM; Mattison RJ; Varghese T; Ganz O; Chappell R; Galipeau J; McDowell KA; Meyers RO; Glazer TA; Kimple RJ
    Cytotherapy; 2022 May; 24(5):534-543. PubMed ID: 35183442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural history and prevention of radiation injury.
    O'Connell AC
    Adv Dent Res; 2000 Dec; 14():57-61. PubMed ID: 11842925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Xerostomia and hypofunction of the salivary glands in cancer therapy.
    Jensen SB; Pedersen AM; Reibel J; Nauntofte B
    Support Care Cancer; 2003 Apr; 11(4):207-25. PubMed ID: 12673459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of xerostomia after radiotherapy on quality of life: results of a questionnaire in head and neck cancer.
    Dirix P; Nuyts S; Vander Poorten V; Delaere P; Van den Bogaert W
    Support Care Cancer; 2008 Feb; 16(2):171-9. PubMed ID: 17618467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Xerostomia induced by radiotherapy: an overview of the physiopathology, clinical evidence, and management of the oral damage.
    Pinna R; Campus G; Cumbo E; Mura I; Milia E
    Ther Clin Risk Manag; 2015; 11():171-88. PubMed ID: 25691810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of salivary gland dosimetry on post-IMRT recovery of saliva output and xerostomia grade for head-and-neck cancer patients treated with or without contralateral submandibular gland sparing: a longitudinal study.
    Wang ZH; Yan C; Zhang ZY; Zhang CP; Hu HS; Tu WY; Kirwan J; Mendenhall WM
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1479-87. PubMed ID: 20934262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgery of the major salivary glands and its impact on salivary flow-A review.
    Burghartz M; Hackenberg S; Sittel C; Hagen R
    Laryngoscope; 2019 Sep; 129(9):2053-2058. PubMed ID: 30478835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal stromal/stem cell therapy for radiation-induced salivary gland hypofunction in animal models: a protocol for a systematic review and meta-analysis.
    Jansson PM; Lynggaard CD; Carlander AF; Jensen SB; Follin B; Hoeeg C; Kousholt BS; Larsen RT; Grønhøj C; Jakobsen KK; Rimborg S; Fischer-Nielsen A; Menon JML; von Buchwald C
    Syst Rev; 2022 Apr; 11(1):72. PubMed ID: 35436971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First-in-man mesenchymal stem cells for radiation-induced xerostomia (MESRIX): study protocol for a randomized controlled trial.
    Grønhøj C; Jensen DH; Glovinski PV; Jensen SB; Bardow A; Oliveri RS; Specht L; Thomsen C; Darkner S; Kiss K; Fischer-Nielsen A; von Buchwald C
    Trials; 2017 Mar; 18(1):108. PubMed ID: 28270226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of radiotherapy-induced salivary hypofunction and consequent xerostomia in patients with oral or head and neck cancer: meta-analysis and literature review.
    Lovelace TL; Fox NF; Sood AJ; Nguyen SA; Day TA
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 May; 117(5):595-607. PubMed ID: 24650370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does radiation dose to the salivary glands and oral cavity predict patient-rated xerostomia and sticky saliva in head and neck cancer patients treated with curative radiotherapy?
    Jellema AP; Doornaert P; Slotman BJ; Leemans CR; Langendijk JA
    Radiother Oncol; 2005 Nov; 77(2):164-71. PubMed ID: 16256229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.